ANALOX LIMITED
Company number 03005200 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
CREDIT ANALYSIS REPORT: ANALOX LIMITED
1. Credit Opinion: APPROVE
Analox Limited presents as a strong credit proposition based on its established trading history (30 years), consistent growth trajectory, and robust balance sheet. The company demonstrates strong debt servicing capability through its growing revenue base (£12.4m in 2023, up from £10.4m in 2022), healthy cash position (£3.13m), and secured long-term defence contracts extending beyond 2026. Net assets have grown steadily from £3.27m (2017) to £5.66m (2023), indicating retained earnings reinvestment rather than over-distribution. The primary caution relates to the significant increase in total liabilities from £2.96m to £6.78m between 2022 and 2023, which warrants clarification but is likely attributable to deferred income from major defence contracts. Overall, this is a well-managed, profitable manufacturing business with strong market positioning in niche gas sensing markets.
2. Financial Strength
Balance Sheet Analysis:
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Total Assets | £12.55m | £8.22m | £8.47m | £7.30m |
| Total Liabilities | £6.78m | £2.96m | £1.95m | £1.51m |
| Net Assets | £5.66m | £5.13m | £5.27m | £4.62m |
| Cash | £3.13m | £0.75m | £2.10m | £2.22m |
Positive Indicators: - Net assets have grown consistently over six years (£3.27m in 2017 to £5.66m in 2023), demonstrating cumulative profitability and retention - Share capital of £30k with shareholders' funds of £5.66m indicates substantial accumulated profits - Cash position strengthened materially in 2023 (£3.13m vs £0.75m in 2022), providing excellent liquidity headroom - Gearing appears conservative given the strong equity base
Areas Requiring Attention: - Total liabilities increased by £3.82m (129%) between 2022 and 2023 whilst net assets only increased by £0.53m. This suggests either: (a) significant deferred income from defence contracts, (b) increased trade creditors, or (c) new borrowings. The nature of these liabilities is critical to understanding leverage - The 2018 accounts showed total liabilities of £8.19m against net assets of £3.83m, suggesting a cyclical pattern of liability fluctuation potentially linked to contract accounting
Equity Quality: Strong – predominantly retained earnings rather than share capital, indicating genuine organic wealth creation.
3. Cash Flow Assessment
Revenue & Profitability: - Turnover growth: £7.26m (2020) → £10.39m (2021) → £10.4m (2022) → £12.4m (2023) - Return on sales (excluding one-off costs): 12.7% (2023) vs 13.7% (2022) – marginal compression but still healthy - Sales per employee: £130k (2023) vs £115k (2022) – improving productivity - Employee numbers grew from 99 to 103, supporting revenue growth
Working Capital Considerations: - Cash of £3.13m against total current liabilities (unknown split) provides comfortable coverage - Dividends of £726k were paid in 2023, demonstrating cash generation capacity whilst retaining sufficient for reinvestment - No final dividend recommended, suggesting prudent cash retention approach
Liquidity Position: - The dramatic improvement in cash from £0.75m (2022) to £3.13m (2023) is noteworthy and likely reflects advance payments or milestone receipts on defence contracts - Directors confirm the company meets day-to-day working capital requirements through cash generated from operations and external borrowings - Going concern basis confirmed by both directors and auditors with no material uncertainties identified
Cash Flow Risk: Low – strong operational cash generation evidenced by dividend payments, growing cash reserves, and long-term contracted revenue streams.
4. Monitoring Points
Priority 1 - Immediate Clarification Required: - Liability Composition: Obtain detailed breakdown of the £6.78m total liabilities. Specifically understand what portion represents deferred income (likely from defence contracts), trade creditors, and any new borrowings. This is essential for accurate leverage assessment - Contract Structure: Understand payment terms and milestone structures on the two major defence contracts to assess cash flow predictability
Priority 2 - Ongoing Monitoring: - Operating Margins: Track return on sales – the decline from 13.7% to 12.7% may indicate inflationary pressure on input costs as flagged in the strategic report - Operational KPIs: OTIF performance declined from 93.1% to 89.6% – monitor for supply chain or capacity constraints - Quality Metrics: DRFT slipped marginally from 99.8% to 99.3% – track for any trend deterioration - Subsidiary Reorganisation: Amoxtec Inc no longer consolidated into Analox Ltd accounts – understand the impact on revenue recognition and intercompany arrangements - Inflation Impact: Directors specifically flagged material and labour cost inflation – monitor margin compression in future periods
Priority 3 - Structural Considerations: - Group Structure: Analox Holdings Limited holds 75%+ of shares, voting rights, and director appointment rights. Understand the broader group structure and any intercompany obligations - Customer Concentration: Defence contracts now represent significant revenue – assess concentration risk and contract renewal/extension prospects post-2026 - FX Exposure: USA subsidiary and international sales create foreign exchange risk despite directors stating it is not material – monitor given sterling volatility
Financial Covenant Recommendations (if lending): - Minimum net assets: £4.0m - Maximum total liabilities to net assets ratio: 1.5:1 - Minimum cash coverage ratio: 1.2:1 (current assets excluding inventory to current liabilities) - Interest cover minimum: 3.0x